Skip to main content
NCBI home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
letter
. 1993;152(5):458–459. doi: 10.1007/BF01955914

Flumazenil reverses diazepam-induced neonatal apnoea and hypotonia

A M Cone 1, S Nadel 2, B Sweeney 3
PMCID: PMC7102282  PMID: 8319721

The content is available as a PDF (258.2 KB).

References

  • 1.Burr W, Sandham P, Judd A. Death after flumazenil. BMJ. 1989;298:1713–1713. doi: 10.1136/bmj.298.6689.1713-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Richard P, Bardol J, Soyez C, Barbier P, Jonville AP, Ramponi N. The use of flumazenil in a neonate. Clin Toxicol. 1991;29:137–140. doi: 10.3109/15563659109038604. [DOI] [PubMed] [Google Scholar]
  • 3.Roald OK, Dahl V. Flunitrazepam intoxication in a child successfully treated with the benzodiazepine antagonist flumazenil. Crit Care Med. 1989;17:1355–1355. doi: 10.1097/00003246-198912000-00023. [DOI] [PubMed] [Google Scholar]
  • 4.Wood C, Oriot D, Robieux I, Devictor D. Flumazenil, a useful antagonist in paediatrics. Arch Fr Pediatr. 1988;45:149–150. [PubMed] [Google Scholar]

Articles from European Journal of Pediatrics are provided here courtesy of Nature Publishing Group

RESOURCES